'Older' age is a risk factor for pelvic inflammatory disease in intrauterine device users

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 12, 2005, Pages 1202-1207

  Viberga, Ilze ^a,b,c   Odlind, Viveca ^b   Berglund, Lars ^b  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b UPPSALA UNIVERSITY   (Sweden)

^c UCR ^*  (Latvia)

Author keywords

Complicated pelvic inflammatory disease; Intrauterine device

Indexed keywords

COPPER INTRAUTERINE DEVICE;

ACADEMIC ACHIEVEMENT; ADULT; AGE; ARTICLE; COMPUTER PROGRAM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; EMPLOYEE; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION COMPLICATION; INTRAUTERINE CONTRACEPTIVE DEVICE; LATVIA; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; UTERINE ENDOCERVIX;

EID: 28344456742     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00810.x     Document Type: Article

References (32)

1. Paavonen J. Pelvic inflammatory disease. From diagnosis to prevention. Dermatol Clin 1998; 16: 747-56, xii.
2. Rein DB, Kassler WJ, Irvin KL, Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: decrising, but still substantial. Obstet Gynecol 2000; 95: 397-402.
3. Family Planning Worldwide 2002 Data Sheet. Washington DC: Population Reference Bureau, 2003.
4. Bergsjo P. Update on the intrauterine contraceptive device. Acta Obstet Gynecol Scand 1992; 71: 163-5.
5. Gareen IF, Greenland S, Morgernstern H. Intrauterine devices and pelvic inflammatory disease: meta-analysis of published studies, 1974-90. Epidemiology 2000; 11: 589-97.
6. Hick DA. What is risk of infection with IUD use? Lancet 1998; 351: 1222-3.
7. Shelton JD. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001; 357: 443.
8. Stadel BV, Schlesselman S. Extent of surgery for pelvic inflammatory disease in relation to duration of intrauterine device use. Obstet Gynecol 1984; 63: 171-7.
9. Rudze L, Caunite A, Eiklone A, Kondrate I, Lazdane G, Strautmane R et al. Reproductive Health of the Population of Latvia: Evaluation and Recommendations. Riga: UNDPA/Ministry of Welfare, 1998.
10. Viberga I, Odlind V, Lazdane G, Kroica J, Berglund L, Olofsson S. Microbiology profile in women with pelvic inflammatory disease in relation to IUD use. Infect Dis Obstet Gynecol (in press).
11. Halperin R, Levinson O, Yaron M, Bukovsky I, Schneider D. Tuboovarian abscess in older women: is the woman's age a risk factor for failed response to conservative treatment? Gynecol Obstet Invest 2003; 55: 211-5.
12. Jamieson DJ, Duerr A, Macasaet MA, Peterson HB, Hillis SD. Risk factors for a complicated clinical course among women hospitalized with pelvic inflammatory disease. Infect Dis Obstet Gynecol 2000; 8: 88-93.
13. Reljic M, Gorisek B. C-reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet 1998; 60: 143-50.
14. Reljic M, But I. Monitoring parameters in the management of patients with tubo-ovarian complexes. Int J Gynaecol Obstet 1999; 64: 273-9.
15. WHO Special Programme of Research, Development and Training in Human Reproduction: Task Force on the Safety and Efficacy of Fertility Regulating Methods. The TCu380A, TCu220C, Multiload 250 and Nova T IUDs at 3, 5, 7 years of use - results from three randomized multicentre trials. Contraception 1990; 42: 141-58.
16. Lovset T. A comparative evaluation of Multiload 250 and Multiload 375 intrauterine devices. Acta Obstet Gynecol Scand 1990; 69: 521-6.
17. United Nations Development Programme et al, Special Programme of Research, Development and Research Training in Human Reproduction. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu200C. Contraception 1997; 56: 341-52.
18. Bonacho I, Pita S, Gomez-Besteiro MI. Eight years with the same IUD. Contraception 1999; 59: 233-6.
19. Edelman DA, Porter CW, van Os WAA. When should intrauterine devices be removed and replaced? Br J Fam Plann 1990; 16: 132-8.
20. Vera SP, Landa TH, Guzman LMR, Cruz LH. [Risk factors associated with pelvic inflammatory disease.] (in Spanish with English Abstract) Ginecol Obstet Mex 2002; 70: 398-403.
21. Gareen IF. Intrauterine devices and pelvic inflammatory disease. Curr Womens Health Rep 2003; 3: 280-7.
22. Penney G, Brechin S, de Souza A, Bankowska U, Belfield T, Gormley M et al. FFPRHC Guidance (January 2004) the copper intrauterine device as long-term contraception. J Fam Plann Reprod Health Care 2004; 30: 29-41.
23. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory diseases: an international perspective. Lancet 1992; 339: 785-8.
24. Wollen AL, Flood PA, Sandvei R. Altered ciliary substructure in the endosalpinx in women using an IUCD. Acta Obstet Gynecol Scand 1990; 69: 307-12.
25. Kjar A, Laursen K, Thormann L, Borggaard O, Lebech PE. Copper release from copper intrauterine devices removed after up to 8 years of use. Contraception 1993; 47: 349-58.
26. Vural B, Vural F, Corakci A, Turkoglu S, Erk A. Does the intrauterine device carry the risk of immunity to sperm? Adv Contracept 1999; 15: 29-35.
27. Bastidas JM, Cano E, Mora N. Copper corrosion - simulated uterine solutions. Contraception 2000; 61: 395-9.
28. Beltran-Garcia MJ, Espinosa A, Herreta N, Perez-Zapata AJ, Beltran-Garcia C, Ogura T. Formation of copper oxychloride and reactive oxygen species as cause of uterine injury during copper oxidation of Cu-IUD. Contraception 2000; 61: 99-103.
29. Anjalika Gupta I, Gupta SK, Ganguly NK. Reactive oxygen intermediates and reactive nitrogen intermediates in copper intrauterine device users. Contraception 1999; 59: 67-70.
30. Amla S, Gupta I, Kausalya S, Ganguly NK. Active oxygen species in copper intrauterine device users. Contraception 1993; 48: 150-6.
31. Pradhan M, Gupta I, Ganguli NK. Nitrites and L-Citrulline levels in cooper intrauterine device users. Contraception 1997; 55: 315-8.
32. Patai K, Berenyi M, Sipos M, Nozal B. Characterization of calcified deposits on contraceptive intrauterine devices. Contraception 1998; 58: 305-8.